Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Retinoic acid affects skin and hair health by working with specific receptors, and its absence can lead to hair loss and skin changes.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Combining different drugs can improve hair loss treatment.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

COVID-19 can harm many body parts, not just the lungs.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.